Merck’s COVID Pill Doesn’t Cut Death Rates in Many Vaxxed Adults

Merck's COVID antiviral molnupiravir speeds up recovery but does not reduce the hospitalization or death rate in higher-risk vaccinated adults, detailed data from a large study showed.
Reuters Health Information